CureGN-Diabetes: Ancillary Study to CureGN

Brief description of study

There are several different types of glomerular diseases, such as minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and immunoglobulin A nephropathy (IgAN). Over time, these diseases may cause kidney damage. Because these kidney diseases are rare, it is difficult for individual researchers to gather a large enough number of people to effectively study underlying causes, identify markers of disease, and identify and evaluate new therapies. The purpose of CureGN is to gather a group of people with glomerular disease to create a source of information and blood and urine samples, so that researchers can easily and effectively study glomerular disease. People with diabetes were excluded from the original CureGN Study, but diabetes is very common and may impact numerous aspects of glomerular disease. CureGN-Diabetes is an ancillary study to CureGN, which includes participants with diabetes AND glomerular disease, so researchers may also understand how these two chronic diseases affect one another.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
glomerular diseases
Age: Between 18 Years - 99 Years
Gender: All

Male or Female, Age 18 or older, Anyone with diabetes and MCD, FSGS, MN or IgAN who has had their first kidney biopsy within the last 5 years,

Updated on 09 Mar 2024. Study ID: 850025

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).